Fundamental Research Division
The DRF at the CEA assemble approximately 6,000 scientists since January 2016.
Researchers from the CEA-Joliot and their partners have studied the efficiency of bio-inspired catalysts at reducing CO2 on the basis of their chemical structure. Their results provide an opportunity to develop catalysts that can be used on a large scale ... as well as reduce the accumulation of CO2 in the atmosphere!
High-level experts from around the world will discuss progress towards achieving energy production from nuclear fusion at an International Atomic Energy Agency (IAEA) meeting next week. The 28th IAEA Fusion Energy Conference (FEC) will take place virtually from 10 to 15 May. It is organized by the IAEA and co-hosted by the ITER Organization and the Government of France through the French Alternative Energies and Atomic Energy Commission (CEA).
Under the impetus of Patrick Landais, the High Commissioner, the FOCUS incentive program has selected the Organoids On a Chip (OOC) project to support interdisciplinary synergies between technological sciences and life sciences within the CEA. The objective is to promote the emergence of breakthrough ideas, concepts or technologies in the biomedical field.
BIAM researchers, together with international partners, have succeeded in developing a contrast agent that improves the accuracy of medical imaging, and that is also capable of treating tumors and delivering localized treatment.
A team from the Iramis (CEA-CNRS) has shown that aluminosilicate nanotubes (imogolites) have an interesting potential for photocatalysis. These light-activated semiconductors could be functionalized to depollute water, in an environmentally friendly way.
In collaboration with the IECB in Bordeaux, a team from the CEA-Joliot has developed a molecule consisting of a hybrid of a peptide and an artificial polymer. This molecule is capable of inhibiting the action of a protein involved in cancers.
As part of an international collaboration, BIAM researchers have successfully produced 3D-printed microswimmers that can be guided by magnetic fields. Ultimately, these devices could be used within the human body for therapeutic purposes.
As part of a European collaboration, researchers at the CEA-Jacob have demonstrated that exposure to aggregates of α-synuclein proteins could reduce the support capacity of the brain’s immune cells, the astrocytes.
A collaboration involving the CEA-IRFM, the European consortium EUROfusion, Iter and American partners has shown that it is possible to protect successfully the internal structures of a fusion reactor against damage caused by very energetic electrons that escape the fusion plasma following a major instability.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.